University of Minnesota develops cancer drug that helps dogs with hemangiosarcomaFebruary 14, 2017The University of Minnesota has announced the breakthrough trial of a new drug that improves survival rates in dogs diagnosed with a cancer called hemangiosarcoma (HSA). The research and results were published recently published in the journal of Molecular Cancer Therapeutics.
SPONSORED CONTENTYour Parasite Protection Recommendation, SimplifiedManaging parasite prevention doesn’t have to be complicated. Discover a single solution that protects against multiple threats. + Learn More
